Nyxoah(NASDAQ:NYXH) 
We are a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, or OSA. Our lead solution is the Genio system, a CE-Marked, patient-centric minimally invasive next- generation hypoglossal neurostimulation therapy for the ...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 6.80
H 6.80
L 5.76
C 6.08
V 85,648
10EMA 6.08
20EMA 6.08
60EMA 6.08
120EMA 6.08
250EMA 6.08